Profile

Róbert obtained his PhD from Charles University in 2024. His early research focused on organocatalysis, which later evolved into the development of antiviral agents targeting influenza A virus and pathogens from the Bunyavirales order. His current work involves the development of green and sustainable methodologies in organic synthesis, alongside the study of non-covalent interactions in organic molecules. Dr. Róbert Reiberger has published peer-reviewed papers in internationally recognized journals such as RSC Medicinal Chemistry, JOC, ChemMedChem, IJMS, and the European Journal of Pharmacology. He is fluent in English, Czech, and Slovak.

Education&Professional Experience

2026.04 – present
Postdoctoral Researcher, Institute for Advanced and Applied Chemical Synthesis, Jinan University, China

2025.01 – 2026.02
Postdoctoral Researcher, IOCB Prague, Czech Academy of Sciences, Czech Republic

2019.09 – 2024.12
PhD (Organic Chemistry), Faculty of Sciences, Charles University & IOCB Prague, Czech Republic. Supervisor: Aleš Machara, PhD
2017.10 – 2019.05
Master’s Degree (Organic Chemistry), Faculty of Sciences, Charles University, Czech Republic
2018.06 – 2018.09
Summer Internship, Drug Discovery, Brain Sciences – School of Medicine, Johns Hopkins University, Baltimore (MD), USA

2014.10 – 2017.06

Bachelor’s Degree (Specialty: Chemistry), Faculty of Sciences, Charles University, Czech Republic

Representative Publications in Recent 5 Years

1. Reiberger, R.; Kráľ, M.; Radilová, K.; Kotačka, T.; Tsalyy, A.; Dračínský, M.; Majer, P.; Konvalinka, J.; Kožíšek, M.; Machara, A. Beyond Natural Flavonoids: Exploring Bioisosterism in Design and Synthesis of Influenza Endonuclease Inhibitors. RSC Med. Chem. 2025, 16, 3030–3048.

2. Kráľ, M.; Kotačka, T.; Reiberger, R.; Panýrková, G.; Radilová, K.; Osifová, Z.; Flieger, M.; Konvalinka, J.; Majer, P.; Kožíšek, M.; Machara, A. 3'-Dehydroxypurpurogallin-4-Carboxamides as Influenza A Endonuclease Inhibitors: Synthesis, Structure-Activity Relationship Analysis, and Structural Characterization of Protein Complex. ChemMedChem2025, 20, 202400577.

3. Čermáková, K.; Gregor, J.; Kráľ, M.; Karlukova, E.; Navrátil, V.; Reiberger, R.; Berenguer Albiñana, C.; Bechynský, V.; Majer, P.; Konvalinka, J.; Machara, A.; Kožíšek, M. The Evaluation of DNA-Linked Inhibitor Antibody and AlphaScreen Assays for High-Throughput Screening of Compounds Targeting the Cap-Binding Domain in Influenza A Polymerase. Eur. J. Pharm. Sci. 2025, 205, 106990.

4. Tsalyy, A.; Kráľ, M.; Reiberger, R.; Majer, P.; Konvalinka, J.; Kožíšek, M.; Machara, A. Design, Synthesis, and Activity Evaluation of C-8 Arylated Luteolin Derivatives as Influenza Endonuclease Inhibitors. Bioorg. Med. Chem. Lett. 2025, 121, 130178.

5. Osifová, Z.; Reiberger, R.; Císařová, I.; Machara, A.; Dračínský, M. Diketo–Ketoenol Tautomers in Curcuminoids: Synthesis, Separation of Tautomers, and Kinetic and Structural Studies. J. Org. Chem. 2022, 87, 10309–10318.

6. Reiberger, R.; Radilová, K.; Kráľ, M.; Zima, V.; Majer, P.; Brynda, J.; Dračínský, M.; Konvalinka, J.; Kožíšek, M.; Machara, A. Synthesis and In Vitro Evaluation of C-7 and C-8 Luteolin Derivatives as Influenza Endonuclease Inhibitors. Int. J. Mol. Sci.2021, 22, 7735.

Research Interests

organic, green and medicinal chemistry, organic synthesis, organocatalysis, and transition metal catalysis, total synthesis.

Contact

Room 406, Biomedical Experiment Building, Jinan University, Zhuhai

Email: reibergerrobert@jnu.edu.cn